Gastroenteropancreatic neuroendocrine tumoursIrvin M. Modlin, Anders Sundin, Steven F. Moss et al.|The Lancet Oncology|2008Cited by 1.8k
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factorsLisa Bodei, Irvin M. Modlin, Mark Kidd et al.|European Journal of Nuclear Medicine and Molecular Imaging|2014Cited by 465
Priorities for Improving the Management of Gastroenteropancreatic Neuroendocrine TumorsIrvin M. Modlin, Elizabeth G. Snyderwine, Steven F. Moss et al.|JNCI Journal of the National Cancer Institute|2008Cited by 226
Gene Network Inference and Biochemical Assessment Delineates GPCR Pathways and CREB Targets in Small Intestinal Neuroendocrine NeoplasiaIgnat Drozdov, Irvin M. Modlin|PLoS ONE|2011Cited by 37
In situ RNA-RNA hybridisation of phospholipase C beta 3 shows lack of expression in neuroendocrine tumours.Peter Stålberg, Britt Skogseid, Donald Granberg et al.|PubMed|2003Cited by 9